Yamogenin
CAS No. 512-06-1
Yamogenin( —— )
Catalog No. M20844 CAS No. 512-06-1
Yamogenin is a diastereomer of diosgenin which we have identified as the compound responsible for the anti-hyperlipidemic effect of fenugreek.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 129 | In Stock |
|
10MG | 189 | In Stock |
|
25MG | 317 | In Stock |
|
50MG | 471 | In Stock |
|
100MG | 681 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYamogenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionYamogenin is a diastereomer of diosgenin which we have identified as the compound responsible for the anti-hyperlipidemic effect of fenugreek.
-
DescriptionYamogenin is a diastereomer of diosgenin which we have identified as the compound responsible for the anti-hyperlipidemic effect of fenugreek.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number512-06-1
-
Formula Weight414.6
-
Molecular FormulaC27H42O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 10 mg/mL (24.12 mM)
-
SMILESC[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C
-
Chemical NameSpirost-5-en-3-ol (3beta25S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Quyen L T Khoi N H Suong N N et al. Steroid Alkaloids and Yamogenin from Solanum spirale1[J]. Planta Medica 1987 53(03):292-293.
molnova catalog
related products
-
Sevelamer HCl
Sevelamer HCl is a phosphate binding drug used to treat hyperphosphatemia via binding to dietary phosphate and prevents its absorption.
-
Tracheloside
Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
-
3,5-Di-O-caffeoylqui...
3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.